Published within
| Type |
Product title / description
|
Pub
|
Price |
Expert View
|
Superdrug's premium skincare and makeup brand, B, is pitched as offering premium products with simplified purchasing and accessible prices. Effective communication of its products' impressive test results should boost sales, but B's affiliation to Superdrug, a retailer associated with value ranges, means that non-Superdrug shoppers who want a premium beauty experience will need some convincing.
Published By Datamonitor
|
16 Jan 2013 |
|
Expert View
|
Over the past three years, Superdrug has been investing across its business to combat increasing competition from grocers and general merchandisers as well as the continuing threat from Boots. Despite this investment, with particular attention paid to its expanding own label range, the retailer still struggles to grow sales.
Published By Datamonitor
|
04 Dec 2012 |
|
Expert View
|
While the EU's decision to halt the process of pharmacy liberalization is clearly based on the merit of one specific case (namely Doc Morris, the leading European online pharmacy), it could herald a sea change in terms of EU decision making. The move away from excessive deregulation towards a slower and more considered approach will bring both costs and benefits for EU consumers and patients.
Published By Datamonitor
|
19 Dec 2008 |
|
CommentWire
|
Schlecker is further strengthening its pole position in EU drug store retailing by buying its German competitor. By retaining the more upmarket Ihr Platz brand and focusing on a two-brand strategy, Schlecker is making the right move in Germany's tough and increasingly polarized retail environment.
Published By Datamonitor
|
04 Oct 2007 |
|
Expert View
|
Lloydspharmacy's parent Celesio announced it is buying 34 pharmacies from the Independent Pharmacy Care Centres chain which, when added to the 29 it recently bought from Manichem takes its community pharmacy chain to over 1,600. While Alliance Boots is preoccupied, Lloydspharmacy is cementing its position and undoubtedly more announcements will follow.
Published By Datamonitor
|
30 Apr 2007 |
|
CommentWire
|
Lloydspharmacy, the second largest community pharmacy chain in the UK behind Alliance Boots, has announced plans to more than double the number of pharmacies located in GP surgeries and health centers from 300 to 750. The move will help the company cement its position in local community healthcare.
Published By Datamonitor
|
01 Mar 2007 |
|
CommentWire
|
Changes in legislation regarding the sale of over-the-counter medicines in Hungary have led two of the country's fuel retailers to announce plans to begin selling non-prescription drugs. With the Hungarian over-the-counter medicines market forecast to see an average annual increase of 5% between 2005 and 2009, Agip and MOL are certain to experience healthy profits from this venture.
Published By Datamonitor
|
07 Dec 2006 |
|
CommentWire
|
As the drugstore market becomes more competitive and saturated in local markets, leading US drugstore retailers Walgreen and CVS are completing acquisitions as their fastest routes to growth and to compete more effectively with non-specialists. This will undoubtedly lead to consumers benefiting from lower prices.
Published By Datamonitor
|
20 Jun 2006 |
|
CommentWire
|
The UK's Competition Appeal Tribunal will hear an objection to the Boots-Alliance UniChem merger from the German owner of Lloydspharmacy, Celesio. But even if the merger does not go ahead, Boots is now taking more interest in the sector, and its well-known brand name will make it a strong rival.
Published By Datamonitor
|
28 Mar 2006 |
|
Expert View
|
Boots Group is expected to announce that it has reached agreement with the Office of Fair Trading regarding its merger with Alliance Unichem and the disposal of 104 stores. Although the divestments will hurt short-term revenue, they may benefit the company's bottom line in the long term by reducing store duplication in small communities.
Published By Datamonitor
|
13 Mar 2006 |
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.